Overview

Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study

Status:
Completed
Trial end date:
2017-01-10
Target enrollment:
Participant gender:
Summary
This is a phase 1 study evaluating the safety and maximum tolerated dose of Liothyronine (T3) in subjects with multiple sclerosis
Phase:
Phase 1
Details
Lead Sponsor:
Oregon Health and Science University
Treatments:
Hormones